John H. Stroger Jr., Hospital of Cook County

Research & Clinical Trials

Minority-Based Community Clinical Oncology Program

Chicago MBCCOP Team 2011

Minority-Based Community Clinical Oncology Program is a grant-funded non-profit institution located in the John H. Stroger, Jr. Hospital of Cook County. Our grant is managed by the Hektoen Institute (E9984-7647-05).

The CCOP Network was created in 1983 as a national mechanism for community-based physicians to partner with academic investigators. The primary goal was to accelerate implementation of NCI clinical trials for cancer prevention, control and treatment. The Minority-Based CCOP program started in 1990 as a companion mechanism to reach areas with large minority populations.

MBCCOP clinic

MBCCOP clinic

Stroger Hospital of Cook County (SHCC) became a Minority-based Community Clinical Oncology Program (MBCCOP) in June 2002.

The SHCC MBCCOP has a strong record of recruiting minority participants to clinical trials with more than 1000 patients accrued to date. The clinical trial menu that is chosen for activation is designed with a view toward the minority population and type of cancers seen by the MBCCOP membership.

Under the direction of the Principal Investigator, Thomas Lad, MD, the SHCC MBCCOP is staffed by 10 NCI-funded employees. It also has institutional support of a part-time non-physician clinical team members and a variety of physician investigators. Cancer care is organized by disease site and is delivered by surgeons, chemotherapists, and radiation oncologists in a cooperative multimodal fashion.

Our mission is to address the shortage of accessible cancer health care resources for Chicago's poor and minority families.

The SHCC MBCCOP plans to develop, strengthen and improve coordinated care and clinical research for minority-underserved patients through growth and expansion with the following specific aims:

  • Continue to develop relationships with current cancer research bases to facilitate broad and improved participation in treatment and prevention/control trials for breast, lung, prostate, gastrointestinal, brain, hematologic, head and neck, and gynecologic cancers.
  • Increase scientific activity at the research base level by initiating and chairing an ECOG group-wide cancer control study concerning reproductive issues of female cancer patients.
  • Increase support for oncologists and other cancer related health care providers.
  • Encourage multidisciplinary cancer care and integrated research.
  • Facilitate transfer of state-of-the-are quality oncology care and new technology to minority-underserved populations in their own communities, through participation in NCI-approved clinical trials.
  • Focus on prevention and control as methods for reducing cancer incidence, morbidity and mortality.
  • Extend and promote research involvement and opportunities with emphasis on the particular needs of the community served, promoting outreach and education.